Andrew S. Judd

Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor

Gang Zhao, Andrew J. Souers, Martin J. Voorbach et al. · Journal of Medicinal Chemistry · 2008 · 140 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X_L Inhibitor

Le Wang, George Doherty, Andrew S. Judd et al. · ACS Medicinal Chemistry Letters · 2020 · 136 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Concise Construction of Novel Bridged Bicyclic Lactams by Sequenced Ugi/RCM/Heck Reactions

T.P. Ribelin, Andrew S. Judd, Irini Akritopoulou‐Zanze et al. · Organic Letters · 2007 · 104 citations

Pharmacy, Chemistry, Medicinal Chemistry +17

Identification of 2-(4-Benzyloxyphenyl)-<i>N</i>- [1-(2-pyrrolidin-1-yl-ethyl)-1<i>H</i>-indazol-6-yl]acetamide, an Orally Efficacious Melanin-Concentrating Hormone Receptor 1 Antagonist for the Treatment of Obesity

Andrew J. Souers, Ju Gao, Michael E. Brune et al. · Journal of Medicinal Chemistry · 2005 · 89 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Slam is an outer membrane protein that is required for the surface display of lipidated virulence factors in Neisseria

Yogesh Hooda, Christine Chieh-Lin Lai, Andrew S. Judd et al. · Nature Microbiology · 2016 · 80 citations

Life Sciences, Microbiology, Molecular Biology +16